Literature DB >> 15322243

Dissociation of [3H]L-glutamate uptake from L-glutamate-induced [3H]D-aspartate release by 3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-4-carboxylic acid and 3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-6-carboxylic acid, two conformationally constrained aspartate and glutamate analogs.

Marcella Funicello1, Paola Conti, Marco De Amici, Carlo De Micheli, Tiziana Mennini, Marco Gobbi.   

Abstract

We characterized the interaction of two conformationally constrained aspartate and glutamate analogs, 3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-4-carboxylic acid (HIP-A) and 3-hydroxy-4,5,6,6a-tetrahydro-3aH-pyrrolo[3,4-d]isoxazole-6-carboxylic acid (HIP-B), with excitatory amino acid transporters (EAATs) in rat brain cortex synaptosomes. HIP-A and HIP-B were potent and noncompetitive inhibitors of [(3)H]L-glutamate uptake, with IC(50) values (17-18 microM) very similar to that of the potent EAAT inhibitor dl-threo-beta-benzyloxyaspartic acid (TBOA). The two compounds had little effect in inducing [(3)H]D-aspartate release from superfused synaptosomes but they potently inhibited l-glutamate-induced [(3)H]D-aspartate release, thus behaving as EAAT blockers, not substrates, in a manner similar to those of TBOA and dihydrokainate (DHK). HIP-A and HIP-B, but not TBOA and DHK, unexpectedly inhibited L-glutamate-induced [(3)H]D-aspartate release with IC(50) values (1.2-1.6 microM) 10 times lower than those required to inhibit [(3)H]L-glutamate uptake. There is therefore a concentration window (1-3 microM) in which the two compounds significantly inhibited l-glutamate-induced release with very little effect on L-glutamate uptake. This selective inhibitory effect required quite long preincubation (>5 min) of synaptosomes with the drugs. At these low concentrations, however, HIP-A and HIP-B had no effect on the EAAT-mediated [(3)H]d-aspartate release induced by altering the ion gradients, indicating that they specifically affect some L-glutamate-triggered process(es)--different from L-glutamate translocation itself--responsible for the induction of reverse transport. These data are inconsistent with the classic model of facilitated exchange-diffusion and provide the first evidence that EAAT-mediated substrate uptake and substrate-induced EAAT-mediated reverse transport are independent. Compounds such as HIP-A and HIP-B could be useful to further clarify the mechanisms underlying these operating modes of transporters.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322243     DOI: 10.1124/mol.66.3.

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  5 in total

1.  Mechanism of inhibition of the glutamate transporter EAAC1 by the conformationally constrained glutamate analogue (+)-HIP-B.

Authors:  Randolph Callender; Armanda Gameiro; Andrea Pinto; Carlo De Micheli; Christof Grewer
Journal:  Biochemistry       Date:  2012-06-27       Impact factor: 3.162

2.  The glial glutamate transporter 1 (GLT1) is expressed by pancreatic beta-cells and prevents glutamate-induced beta-cell death.

Authors:  Eliana S Di Cairano; Alberto M Davalli; Lucia Perego; Silvia Sala; V Franca Sacchi; Stefano La Rosa; Giovanna Finzi; Claudia Placidi; Carlo Capella; Paola Conti; Victoria E Centonze; Francesca Casiraghi; Federico Bertuzzi; Franco Folli; Carla Perego
Journal:  J Biol Chem       Date:  2011-02-18       Impact factor: 5.157

3.  Dynamic Gradient of Glutamate Across the Membrane: Glutamate/Aspartate-Induced Changes in the Ambient Level of L-[14C]glutamate and D-[3H]aspartate in Rat Brain Nerve Terminals.

Authors:  T Borisova; A Borysov; A Pastukhov; N Krisanova
Journal:  Cell Mol Neurobiol       Date:  2016-02-17       Impact factor: 5.046

Review 4.  SLC1 glutamate transporters.

Authors:  Christof Grewer; Armanda Gameiro; Thomas Rauen
Journal:  Pflugers Arch       Date:  2013-11-19       Impact factor: 3.657

5.  Transport Reversal during Heteroexchange: A Kinetic Study.

Authors:  V Makarov; L Kucheryavykh; Y Kucheryavykh; A Rivera; M J Eaton; S N Skatchkov; M Inyushin
Journal:  J Biophys       Date:  2013-10-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.